Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Caris Life Sciences (CAI) Other Gross PP&E Adjustments (2024 - 2025)

Caris Life Sciences has reported Other Gross PP&E Adjustments over the past 2 years, most recently at -$14.4 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$14.4 million for Q4 2025, up 64.92% from a year ago — trailing twelve months through Dec 2025 was -$14.4 million (up 64.92% YoY), and the annual figure for FY2025 was -$14.4 million, up 64.92%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$14.4 million at Caris Life Sciences, up from -$40.9 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CAI hit a ceiling of -$14.4 million in Q4 2025 and a floor of -$40.9 million in Q4 2024.